Market Overview

CASI Pharmaceuticals, Inc. (CASI)

3.56 -0.07 (-1.93%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2021
Pre-Market
EPS:
REV:
-0.14
4.242M



Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
-0.09
3.406M



Q4 2020
Pre-Market
EPS:
REV:
-0.13
1.344M



Q3 2020
Pre-Market
EPS:
REV:
-0.10
2.787M
-0.05
3.44M
-0.14
4.242M
-180%
23.31%
Q2 2020
Pre-Market
EPS:
REV:
-0.16
0
-0.08
3.75M
-0.09
2.671M
-12.5%
-28.77%
Q1 2020
Pre-Market
EPS:
REV:
-0.09
0
-0.11
790K
-0.09
3.406M
18.18%
331.14%
Q4 2019
Pre-Market
EPS:
REV:
-0.10

-0.13
1.344M

Q3 2019
Pre-Market
EPS:
REV:
-0.10

-0.10
2.787M

Q2 2019
Pre-Market
EPS:
REV:
-0.07
0

-0.16
0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!